Brought to you by 
IDEAYA brings in $46mm through Series A round
04 May 2016
Executive Summary
Oncology drug discovery start-up IDEAYA Biosciences Inc. raised $46mm through its Series A round. Seed investor 5AM Ventures participated, along with Canaan Partners, Celgene, WuXi Healthcare Ventures, Novartis Institutes for BioMedical Research, and Alexandria Real Estate. Canaan joined the company's board of directors and Celgene and WuXi joined as board advisors.
Deal Industry
- Biotechnology
- Pharmaceuticals
-
Pharmaceuticals
- Vaccines
Deal Status
- Final
Deal Type
-
Financing
- Venture Financing
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
IDEAYA brings in $46mm through Series A round
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice